Diabetic Neuropathy Treatment in Chalfont, PA
Board-certified Pain Specialists
Diabetic Neuropathy Treatment in Chalfont, PA
Diabetic neuropathy treatment in Chalfont starts with an accurate diagnosis and a personalized care plan from our board-certified pain specialists. At Pennsylvania Pain & Spine Institute, our team works with patients to identify the specific type of nerve damage. From there, we match it to the most effective evidence-based therapy. Importantly, our options range from advanced diagnostic testing to in-office Spinal Cord Stimulation (SCS). Each one targets the burning, tingling, and numbness that interfere with daily life.
✅ Burning, tingling, or numbness in your feet
✅ Sharp, electric, or shooting pain in your legs
✅ Loss of sensation, balance problems, or unsteady walking
✅ Foot pain that worsens at night or disrupts sleep
✅ Sensitivity to touch, pressure, or temperature changes
DIABETIC NEUROPATHY SPECIALISTS
What Causes Diabetic Neuropathy?
Diabetic neuropathy develops when chronically high blood sugar damages the nerves. Most often, it affects the long sensory nerves that reach the feet and legs. Over time, this damage can make walking, balance, and everyday activities harder. In most cases, several factors work together to cause or worsen it. Some of the most common causes of diabetic neuropathy include:
✅ High Blood Sugar
✅ Long-Standing Diabetes
✅ Poor Glycemic Control
✅ Vitamin B12 Deficiency
✅ Smoking or Heavy Alcohol Use
✅ High Triglycerides or Blood Pressure
✅ Kidney or Thyroid Disease
Understanding Diabetic Neuropathy
Diabetic neuropathy is nerve damage caused by chronically high blood sugar. Over time, elevated glucose levels injure the small blood vessels that feed the nerves, particularly the long sensory nerves that run to the feet and lower legs. As a result, signals between the brain and the extremities become distorted. The most common form, distal symmetric polyneuropathy (also called diabetic peripheral neuropathy or DPN), typically begins in the toes and spreads upward in a “stocking” pattern.
According to the American Diabetes Association, roughly half of all people with diabetes will develop some form of neuropathy during their lifetime (Pop-Busui et al., 2017). Many patients describe a familiar progression. First, the soles of the feet start to feel slightly numb. Gradually, the numbness gives way to burning, prickling, or electric jolts that worsen at night. Eventually, balance suffers and walking on uneven ground feels unsafe.
Notably, painful diabetic neuropathy is one of the most under-treated complications of diabetes. In many cases, patients are told to “tighten up” blood sugar and accept the discomfort. However, modern interventional pain management offers much more. Our team works with patients to confirm the diagnosis, identify reversible contributors, and build a treatment plan around evidence-based therapies that actually reduce nerve pain.
Diabetic Neuropathy Treatment Options
Spinal Cord Stimulation (SCS)
A small implanted device delivers gentle electrical signals to the spinal cord, interrupting pain messages before they reach the brain. Dr. Bozak performs the full SCS procedure in our Chalfont office, from trial to permanent implant.
*This is done outpatient and does not require anesthesia
Qutenza Capsaicin Patch Therapy
A high-concentration capsaicin (8%) patch applied in-office for 30 to 60 minutes. Specifically targeted at localized neuropathic pain, with effects lasting weeks to months from a single application.
*This is done outpatient and does not require anesthesia
Small Fiber Neuropathy Biopsy
A 3mm in-office skin biopsy that measures intraepidermal nerve fiber density (IENFD). Importantly, it can confirm small fiber neuropathy when standard nerve conduction studies look normal.
*This is done outpatient and does not require anesthesia
Minimally Invasive, Research-Supported Diabetic Neuropathy Treatments
Spinal Cord Stimulation (SCS) for Painful Diabetic Neuropathy
Spinal Cord Stimulation is one of the most significant advances in painful diabetic neuropathy care over the past decade. The procedure uses a small, programmable device implanted under the skin that sends mild electrical signals to the spinal cord. Consequently, those signals interrupt the pain messages traveling from the feet and legs before they ever reach the brain.
Importantly, SCS is not a medication. As a result, it avoids the sedation, weight gain, and cognitive fog that often come with oral neuropathy drugs. The procedure happens in two stages. First, a trial lead is placed through a small needle to confirm the device reduces your pain. Then, if the trial works, a permanent device is placed in a brief outpatient procedure.
“At 3 months, 79% of patients receiving 10-kHz Spinal Cord Stimulation plus conventional medical management responded with at least 50% pain relief, compared with 5% receiving conventional medical management alone. Improvements in pain, sleep, and quality of life were maintained at 24 months.”
— Petersen EA, et al. JAMA Neurology, 2021 (SENZA-PDN trial) (PubMed)
*Outpatient. Does not require general anesthesia.
Qutenza Capsaicin Patch Therapy
Qutenza is a high-concentration capsaicin patch (8%) applied directly to the painful skin. For instance, the patch sits on the soles of the feet for 30 to 60 minutes while a clinician monitors comfort. The active ingredient comes from chili peppers, but at this concentration it temporarily desensitizes the specific pain-signaling nerves in the skin.
By contrast with daily oral medications, a single Qutenza application can reduce neuropathic pain for weeks to months. Furthermore, because the treatment stays at the skin level, it does not produce the systemic side effects that limit gabapentin, pregabalin, or duloxetine for many patients.
“In a pooled analysis of 1,313 patients across seven controlled trials, the high-concentration capsaicin 8% patch produced significant and sustained reductions in neuropathic pain compared with low-dose control.”
— Mou J, et al. Pain, 2013 (PubMed)
*Outpatient. Does not require anesthesia.
Small Fiber Neuropathy Biopsy (Diagnostic)
Standard nerve conduction studies measure only the large nerve fibers. However, painful diabetic neuropathy often begins in the small fibers, which carry pain and temperature signals. As a result, many patients with real, debilitating nerve pain show “normal” EMG results and leave without answers. A small fiber neuropathy biopsy solves that gap.
The procedure is straightforward. First, a 3mm punch biopsy is taken under local anesthetic, usually from two sites (above the ankle and below the hip). The sample is then sent to a specialized laboratory that counts intraepidermal nerve fiber density (IENFD). In most cases, the entire in-office portion takes 10 to 15 minutes.
“Skin biopsy with quantification of intraepidermal nerve fiber density is a reliable and reproducible technique for the diagnosis of small fiber neuropathy.”
— Lauria G, et al. 2012 (PubMed)
*Outpatient. Does not require anesthesia.
Medication Management & Topical Therapies
While interventional therapies do the heavy lifting for moderate-to-severe pain, medication still plays a role. Specifically, our team prescribes anticonvulsants (gabapentin, pregabalin), neuropathic-dose antidepressants (duloxetine, nortriptyline), and topical lidocaine or compounded creams. By contrast with general primary care, we adjust each regimen based on the type and distribution of nerve pain rather than a one-size-fits-all dose.
Frequently Asked Questions About Diabetic Neuropathy
Can diabetic neuropathy be reversed?
Is Spinal Cord Stimulation safe for people with diabetes?
Yes. In fact, the landmark SENZA-PDN trial specifically studied patients with painful diabetic neuropathy and found no unexpected safety concerns (Petersen et al., 2021). Importantly, every candidate undergoes a trial period first to confirm meaningful pain relief before any permanent device is placed.
What's the difference between large fiber and small fiber neuropathy?
When should I see a pain specialist for foot numbness or burning?
If your primary care doctor or endocrinologist has confirmed diabetes and you are experiencing pain, numbness, or burning that interferes with sleep, walking, or daily activities, it is time to consult a pain specialist. Particularly when over-the-counter medications and standard prescriptions aren’t enough, our team can evaluate whether interventional options like SCS or Qutenza are appropriate.
Does insurance cover Spinal Cord Stimulation for diabetic neuropathy?
Common Symptoms of Diabetic Neuropathy
- Burning, tingling, or “pins and needles” in the feet
- Numbness or reduced sensation in the toes and soles
- Sharp, shooting, or electric pain in the legs
- Increased sensitivity to touch, pressure, or temperature
- Foot pain that worsens at night
- Loss of balance or unsteady walking
- Muscle weakness in the feet or lower legs
- Slow-healing cuts, sores, or ulcers on the feet
How We Diagnose Diabetic Neuropathy
- Detailed medical history and symptom mapping
- Physical and neurological examination
- Monofilament, vibration, and pinprick testing
- Electromyography (EMG) and nerve conduction studies for large fiber involvement
- Small fiber neuropathy biopsy for small fiber involvement
- Bloodwork to rule out vitamin deficiencies, thyroid issues, and autoimmune contributors
- Review of medications that may worsen neuropathy
Research insight:In the SENZA-PDN randomized controlled trial of 216 patients with painful diabetic neuropathy refractory to medications, 79% of patients receiving 10-kHz Spinal Cord Stimulation achieved at least 50% pain relief at 3 months, compared with 5% receiving conventional medical management alone. Notably, the improvements in pain, sleep quality, and overall function were maintained through 24 months of follow-up (Petersen et al., JAMA Neurology, 2021).
Common Causes & Contributors to Diabetic Neuropathy
- Chronically elevated blood sugar. Over time, high glucose damages the small blood vessels that supply the nerves, leading to gradual nerve fiber loss.
- Duration of diabetes. Typically, the longer a patient has had diabetes, the higher the risk of neuropathy.
- Poor glycemic control. Wide swings in blood sugar accelerate nerve damage even when average levels look acceptable.
- Metabolic factors. Specifically, high triglycerides, high blood pressure, and obesity each independently increase risk.
- Smoking and heavy alcohol use. Both reduce blood flow to the small nerves and worsen damage.
- Vitamin B12 deficiency. Often overlooked, but particularly common in patients on long-term metformin therapy.
- Coexisting conditions. For example, kidney disease, thyroid disorders, and certain autoimmune conditions can compound diabetic nerve injury.
Why Choose PA Pain & Spine Institute?
- Board-certified pain specialists. Our providers are fellowship-trained in interventional pain management and physical medicine & rehabilitation (PM&R).
- In-office Spinal Cord Stimulation. Bozak performs the entire SCS process, from trial to permanent implant, at our Chalfont office. As a result, patients avoid the hospital setting entirely.
- Advanced diagnostic testing. Including small fiber neuropathy biopsy, EMG, and nerve conduction studies, all available on-site.
- Evidence-based care. Every recommendation we make is grounded in peer-reviewed research, not marketing.
- Personalized care plans. Our team works with each patient to match the treatment to the specific type and severity of nerve damage.
- Local and accessible. Two Bucks County offices in Chalfont and Quakertown, with same-week appointments often available.
- Coordinated with your diabetes care. We communicate with your endocrinologist and primary care team to keep your full care plan aligned.
Take the Next Step
If burning, tingling, or numbness in your feet is interfering with sleep, balance, or daily activity, it is time for a thorough evaluation. Our team will review your diabetes history, examine your nerve function, and discuss every option from medication adjustments to advanced interventional therapies.
Schedule a consultation to:
- Receive a complete neurological evaluation from a board-certified pain specialist
- Confirm the type of nerve damage with appropriate diagnostic testing
- Review minimally invasive options including Spinal Cord Stimulation and Qutenza
- Build a personalized care plan coordinated with your existing diabetes team
- Explore whether regenerative therapies or interventional injections fit your situation
References
- Petersen EA, Stauss TG, Scowcroft JA, et al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial. JAMA Neurology. 2021;78(6):687–698. PubMed: 33818600 | doi:10.1001/jamaneurol.2021.0538
- Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154. PubMed: 27999003
- Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Efficacy of Qutenza (capsaicin) 8% patch for neuropathic pain: A meta-analysis of the Qutenza Clinical Trials Database. Pain. 2013;154(9):1632–1639. PubMed: 23707278
- Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurology. 2008;7(12):1106–1112. PubMed: 18977178
- Lauria G, Hsieh ST, Johansson O, et al. Small fibre neuropathy. Current Opinion in Neurology. 2012. PubMed: 22570215
- Lauria G, Bakkers M, Schmitz C, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. PubMed: 20642627
The information on this page is for general educational purposes only and does not constitute medical advice. Treatment recommendations are based on individual clinical evaluation. Individual results may vary, and no specific outcomes are guaranteed. This content does not create a provider–patient relationship.
